Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca collaborates with Cambridge medical research institutions to advance cancer research
-
AstraZeneca Completes Acquisition Of Pearl Therapeutics
-
AstraZeneca and Bristol-Myers Squibb announce top-line results for SAVOR-TIMI-53 cardiovascular outcomes trial of ONGLYZA® (SAXAGLIPTIN)
-
AstraZeneca selects location for new global R&D centre and corporate headquarters in Cambridge, UK
-
MedImmune, AstraZeneca’s biologics arm, and NGM Biopharmaceuticals announce agreement to discover and develop therapies for diabetes and obesity
-
AstraZeneca to acquire Pearl Therapeutics to strengthen respiratory portfolio
-
AstraZeneca announces top-line results from Phase III OSKIRA Trials of FOSTAMATINIB and decision not to proceed with regulatory filings
-
AstraZeneca enters agreement with Hanmi Pharmaceuticals and Amneal Pharmaceuticals in US NEXIUM patent litigation
-
AstraZeneca to acquire Omthera Pharmaceuticals including NDA-ready novel dyslipidemia treatment to complement cardiovascular portfolio
-
US Appeals Court issues a temporary injunction pending appeal against distribution of generic PULMICORT RESPULES
Latest articles and press releases
All of our latest press releases and articles are available to explore
